Preventive consulting focuses on preventive application of cannabinoids to improve overall health and wellbeing, to address poor sleeping patterns, and to improve resistance to stress. Patients in this case do not have a diagnosis of chronic disease or any pharmacological therapy.
Patients provide the Council with written information about their illness or problem (patient self-assessment). The Clinic shall issue a written opinion and indicative recommendations within one week. It is possible to continue consultations afterwards, mainly to optimize dosing.
Diagnostic patient assessment focuses on the use of cannabinoids as an add-on therapy in chronic diseases and in case of concomitant use of drugs. The suitability of cannabinoid use for an existing diagnosis is checked individually based on published studies. The expression of cannabinoid receptors on the affected organs or tissues and their specificity (CB1, CB2, TRP receptor family) is reviewed in the scientific literature. Possible interactions with existing drugs are examined and the dosage and route of administration of cannabinoids are advised.
The patient provides the council with their medical record, including histological findings, indicating medications and their daily doses, and the symptoms that trouble them despite the therapy they receive. The Council shall issue a written opinion and indicative recommendations within one week. Patients with more severe medical conditions are treated with priority.
If necessary, patients are also provided with periodic consultation and assessment of the condition and, if needed, optimization of the dosing regimen.
Pediatric patients are treated pro bono as part of an expert medical consultation.
When sensible, a video consultation may be proposed as an additional way to treat patients. Video consultations are available as an additional step after written consultation has been provided. A video consultation lasts one hour and is made via Zoom software. Clients need to have a good internet connection.